pediatric cancer

ASCO 2022 Lymphoma In-Depth Bookmark

Presented by Cancer Therapy Advisor, this collection of stories covers new developments in lymphoma treatment that were presented at the 2022 annual meeting of the American Society of Clinical Oncology.

.

Palliative Care Options for a Young Adult Patient with a Diffuse Intrinsic Pontine Glioma Bookmark

This clinical case study published in the scientific journal Cureus suggests that intelligent, compassionate, palliative care is likely the best approach to this very difficult brain tumor.

.

DIPG All-In-Initiative Awards $35,000 Grant for Pediatric Brain Tumor Research Bookmark

As announced by Cancer Commons partner the Musella Foundation For Brain Tumor Research & Information, Inc., a collaboration of groups has announced funding to support research into possible treatments for pediatric diffuse intrinsic pontine glioma (DIPG).

.

Pediatric Cancer: The “Day One Talk” Bookmark

Article from the Journal of Clinical Oncology, curated by Cancer Commons founder Marty Tenenbaum, PhD.

This piece discusses a “method of delivering bad news to parents of children with cancer in hopes that our approach may be helpful to others and may spur discussion.”

.

FDA Grants Rare Pediatric Disease Designation to ONC201 for the Treatment of H3 K27M-Mutant Glioma Bookmark

Press release from Oncoceutics curated by Executive Director Erika Vial Monteverdi.

The U.S. Food and Drug Administration has granted Rare Pediatric Disease Designation to the drug ONC201 for treating a type of brain tumor known as “H3 K27M-mutant glioma,” which is primarily found in children. Alongside the Musella Foundation For Brain Tumor Research & Information, Inc, and the company xCures, Cancer Commons has been supporting this program to help patients in need.

Go to full article published by Novocure on Business Wire.

If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

Accelerating Children’s Access to New Treatments for High Risk Brain Tumors Bookmark

Article from Michigan Health Lab curated by Editor in Chief George Lundberg, MD, who notes: 

Children with serious brain tumors need access to as many clinical trials as possible. This new consortium will encourage that.

Go to full article published by Michigan Health Lab.

If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

Risk of a Second Cancer in Canadians Diagnosed with a First Cancer in Childhood or Adolescence Bookmark

Research paper from EClinicalMedicine curated by Editor in Chief George Lundberg, MD, who notes: 

People who survive after treatment for childhood cancers have a greatly increased likelihood of developing a second cancer, with younger patients at greatest risk.

Go to full paper published in EClinicalMedicine.

If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

Scientists Find Promising Drug Combination Against Lethal Childhood Brain Cancers Bookmark

Article from EurekAlert curated by Editor in Chief George Lundberg, MD, who notes: 

Researchers have shown that a combination therapy is effective against cancer cells in test-tube experiments and laboratory animals. It has not yet been tested in humans.

Go to full article published by EurekAlert.

If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

International Team Discovers Unique Pathway for Treating Deadly Children’s Brain Cancer Bookmark

Article from ScienceDaily curated by Editor in Chief George Lundberg, MD, who notes: 

A genetic mutation known as PPN1D has been found to be a possible point of attack for research into the childhood cancer diffuse intrinsic pontine glioma (DIPG).

Go to full article published by ScienceDaily.